Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2017, vol. 26, nr 4, July, p. 581–586

doi: 10.17219/acem/62453

PubMed ID: 28691410

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The risk of plasma vitamin A, C, E and D deficiency in patients with metabolic syndrome: A case-control study

Małgorzata Godala1,A,B,C,D,F, Izabela Materek-Kuśmierkiewicz2,A,B,D, Dariusz Moczulski2,A,E, Maciej Rutkowski3,B, Franciszek Szatko4,A,F, Ewelina Gaszyńska4,B,C, Sławomir Tokarski5,B,C, Jan Kowalski6,E,F

1 Department of Nutrition and Epidemiology, Chair of Hygiene and Epidemiology, Medical University of Łódz, Poland

2 Department of Internal Medicine and Nephrodiabetology, Chair of Internal Diseases and Cardiology, Medical University of Łódz, Poland

3 Department of Military Toxicology and Radiological Protection, Medical University of Łódz, Poland

4 Department of Hygiene and Health Promotion, Chair of Hygiene and Epidemiology, Medical University of Łódz, Poland

5 Faculty of Medicine, University of Rzeszów, Poland

6 Department of Internal and Infectious Diseases, Medical University of Łódz, Poland


Background. The increasing incidence of metabolic diseases such as obesity or diabetes have made them a major public health problem. Increasing oxidative stress induced by reactive oxygen species, which initiate the oxidative adverse changes in the cell, is mentioned, among other risk factors, to underlie these diseases. Vitamin A, C and E are listed among the non-enzymatic mechanisms counteracting this phenomenon. Vitamin D deficiency is also associated with cardiovascular diseases.
Objectives. The aim of the study was to assess the risk of vitamin A, C, E and D deficit in the plasma of metabolic syndrome (MS) patients.
Material and Methods. The study included 191 patients with MS and 98 subjects without MS. Loglinear analysis was used in the assessment of mutual interactions between the vitamin concentration and the analysis of classification by ROC curves to predict the frequency of vitamin deficiency in MS patients.
Results. A correlation was found between the plasma level of vitamins in the group of MS patients. Vitamin A concentration correlated with that of vitamin C (r = 0.51, p = 0.0000), vitamin D (r = 0.49, p = 0.0000) and E (r = 0.32, p = 0.0001). The plasma level of vitamin D correlated with the level of vitamin E (r = 0.46, p = 0.00000) and vitamin C (r = 0.37, p = 0.0000). Regression analysis showed a correlation between the concentration of the tested vitamins in patients with MS. Interactions were observed between vitamins C and A and between C and D. HDL cholesterol level was lower in patients with vitamin A deficiency compared to patients with its normal level.
Conclusion. The plasma levels of vitamin A, C, E and D were significantly lower in patients with MS than in healthy subjects and they mutually correlated with each other. The normalization of glucose and HDL level may contribute to the regulation of the concentration of vitamin A in patients with MS.

Key words

metabolic syndrome, antioxidant vitamins, vitamin D deficiency

References (30)

  1. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentration. Findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003;52:2346–2352.
  2. Beydoun MA, Shroff MR, Chen X, Beydoun HA, Wang Y, Zonderman AB. Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys. J Nutr. 2011;141:903–913.
  3. Płudowski P, Karczmarewicz E, Bayer M, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe — recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Pol J Endocrinol. 2013;64(3):1–9.
  4. Muscogiuri G, Sorice GP, Ajjan R, et al. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis. 2012;22:81–87.
  5. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet. 2005;366:1059–1062.
  6. Rutkowski M, Grzegorczyk K, Greger J. Adaptation of the phosphotungstate method to determine reduced and oxidized vitamin C in blood plasma. Zeitschr Naturforsch. 2004;59:762–767.
  7. Rutkowski M, Grzegorczyk K, Kędziora J. Laboratory convenient modification of Bessey method for vitamin A determination in blood plasma. J Physiol Pharmacol. 2006;57:221–226.
  8. Rutkowski M, Grzegorczyk K, Paradowski MT. Colorimetric determination of total vitamin E concentration in plasma – own modification of Tsen’s method. Diagn Lab. 2005;41:375–385.
  9. Cahill L, Corey PN, El-Sohemy A. Vitamin C deficiency in a population of young Canadian adults. Am J Epidemiol. 2009;170:464–471.
  10. Muldowney S, Lucey AJ, Paschos G, et al. Relationship between vitamin D status and cardio-metabolic risk factors in young European adults. Ann Nutr Metab. 2011;58(2):85–93.
  11. Illison VK, de Oliveira AM, Rondó PHC, D’Abronzo FH, Campos KF. The relation between plasma alpha-tocoferol concentration and vitamin E intake in patients with type 2 diabetes mellitus. Int J Vitam Nutr Res. 2011;81:12–20.
  12. Odum EP, Orluwene CG, Ejilemele AA, Wakwe VC. Antioxidant status of subject with metabolic syndrome in Port Harcourt, Nigeria. Niger Postgrad Med J. 2012;19:199–203.
  13. Sharma P, Mishra S, Ajmera P, Mathur S. Oxidative stress in metabolic syndrome. Indian J Clin Biochem. 2005;20:145–149.
  14. Singh RB, Ghosh S, Niaz MA, et al. Dietary intake, plasma levels of antioxidant vitamins and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol. 1995;76(17):1233–1238.
  15. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiology. 2012;109:359–363.
  16. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vázquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr. 2007;26:573–580.
  17. Forrest KYZ, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2010;31:48–54.
  18. John WG, Noonan K, Mannan N, Boucher BJ. Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis. Am J Clin Nutr. 2005;82:517–522.
  19. Chiu KC, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr. 2004;79:820–825.
  20. Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: Nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007;85:860–868.
  21. Czernichow S, Vergnaud AC, Galan P, et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentration with risk of metabolic syndrome in adults. Am J Clin Nutr. 2009;90:329–335.
  22. Li Y, Schellhorn HE. New developments and novel therapeutic perspectives for vitamin C. J Nutr. 2007;137:2171–2184.
  23. Palace VP, Khaper N, Qin Q, Singal PK. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med. 1999;26:746–761.
  24. Edge R, McGarvey DJ, Truscott TG. The carotenoids as anti-oxidants – a review. J Photochem Photobiol. 1997;41:189–200.
  25. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361:2017–2023.
  26. Trasino SE, Benoit YD, Gudas LJ. Vitamin A deficiency causes hyperglycemia and loss of pancreatic β-cell mass. J Biol Chem. 2015;290:1456–1473.
  27. Pocobelli G, Ulrike P, Kristal AR, White E. Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality. Am J Epidemiol. 2009;170:472–83.
  28. Soni MG, Thurmind S, MillerER, Spriggs T, Bendich A, Omaye ST. Safety of vitamins and minerals: Controversies and perspective. Toxicol Science. 2010;118(2):348–355.
  29. Bergström T, Bergman J, Möller L. Vitamin A and C compounds permitted in supplements differ in their abilities to affect cell viability, DNA and the DNA nucleoside deoxyguanosine. Mutagenesis. 2011;26(6):735–744.
  30. Mayne ST. Oxidative stress, dietary antioxidant supplements, and health: Is the glass half full or half empty? Cancer Epidemiol Biomarkers Prev. 2013;22:2145–2147.